email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
91 - 105
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
AlphaGen and ArtBio Form China-US Partnership for Radioligand Therapies
$5.00
Available
Mabwell OK’d to Begin US Clinical Trials of ADC for Solid Tumors
$5.00
Available
Biocytogen Signs Three-Year Antibody Discovery Pact with Gilead Sciences
$5.00
Available
Jacobio to Start Phase III Trial of Novel Combination in NSCLC with KRAS G12C Mutations
$5.00
Available
CASI Launches Pralatrexate in China for R/R Peripheral T-cell Lymphoma
$5.00
Available
AusperBio Updates Clinical Progress of Antisense Oligonucleotide Therapy for HBV
$5.00
Available
LianBio to Shut Down Operations; Will Distribute $528 Million to Shareholders
$5.00
Available
Chugai Pharma Approved for China Launch of Complement Inhibitor 5 for NPH
$5.00
Available
Yiviva Signs MOU with AstraZeneca to Develop New Drugs based on TCM Therapies
$5.00
Available
Hengrui Launches Antifungal in China for Vulvovaginal Candidiasis
$5.00
Available
Bayer Signs Letter of Intent to Market Trinity’s Glucose Monitor in China and India
$5.00
Available
Eisai Launches Leqembi, an Alzheimer’s Drug, in China for Early-Stage Disease
$5.00
Available
China Medical System Acquires China Rights to Phosphate Binder from Winhealth
$5.00
Available
I-Mab Divests China Operations to Become Fully US-Based Biopharma
$5.00
Available
Innovent Says NDA for Dual Agonist Obesity Therapy Accepted for China Review
$5.00
Available